About: http://data.cimple.eu/news-article/2a0210b896f517f9a783da39bda0b6634e4b10a489decda1456933f6     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Britain is spending £29.3 million ($40.6 million, 33.8 million euros) on new coronavirus vaccine laboratories in an effort to "future-proof the country from the threat of new variants", the government said Wednesday. The new labs at the Porton Down research facility in southwest England will be used to test the effectiveness of vaccines against variants and speed up their deployment, according to Health Secretary Matt Hancock. "We've backed UK science from the very start of this pandemic and this multi-million pound funding for a state-of-the-art vaccine testing facility at Porton Down will enable us to further future-proof the country from the threat of new variants," he said. "This announcement is yet another critical way we will build back better to protect the country over the coming months and years," he added. Porton Down is the secretive army base near Salisbury in south west England that identified the nerve agent used to poison a Russian ex-spy in 2018. The Defence Science and Technology Laboratory -- its official name -- employs 3,000 scientists across a sprawling rural site. It was founded in 1916 to counter German chemical attacks in World War I, which initially involved chlorine and then mustard gas and phosgene. New funding will increase the site's current blood testing capacity from 700 to 3,000 samples a week, enabling scientists to measure more quickly the levels of antibodies that are generated by the vaccines. "The expanded testing capacity at Porton Down will ensure the UK stays one step ahead of the virus and is in the best possible position to respond to new threats from COVID-19 as quickly as possible," the government said. Britain has been one of the worst-hit countries in the world by the pandemic, recording more than 127,500 deaths. But restrictions are being eased following a successful vaccine rollout, with daily deaths down into single figures. Leading scientists are still concerned that a new variant resistant to current vaccines may lead to a new surge. "A new variant that can escape the current vaccines is the greatest risk of a third wave," said Jenny Harries, chief executive at the UK Health Security Agency (UKHSA). "This new investment will help us stay one step ahead of the virus by doubling our capacity to test vaccine effectiveness against emerging variants." jwp/phz/bp
schema:headline
  • UK puts £29m into new labs to tackle Covid variants
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software